基于水凝的栓塞剂的进展:按治疗机制分类
Shenbo Zhang1, Rui Lv1, Zhe Zhang1
1Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Cancer medicine
|October 23, 2024
概括
本综述根据治疗机制对水凝栓塞剂进行了分类,有助于开发用于透气管动脉栓塞 (TAE) 的新药. 它强调了这些有前途的材料的进展和未来方向.
科学领域:
- 干预性放射学 干预性放射学
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
背景情况:
- 透管动脉栓塞 (TAE) 是一种关键的干预性放射学程序.
- 基于水凝的栓塞剂具有独特的相位过渡和药物加载特性.
- 目前对水凝栓塞剂的分类缺乏明确性.
研究的目的:
- 为凝栓塞剂建立一个新的分类框架.
- 基于它们的治疗机制来分析药物:运输,积累,相互作用和消除.
- 识别当前的挑战,争议,以及该领域的未来研究途径.
主要方法:
- 临床前试验的系统文献综述.
- 数据来源于2004年至2024年间的PubMed出版物.
- 专注于根据它们的功能机制对药物进行分类.
主要成果:
- 水凝栓塞剂根据其特定的治疗机制进行分类.
- 大多数药物表现出针对目标血管系统的积累和相互作用的优化设计.
- 新兴趋势表明,人们正在转向多功能水凝栓塞剂.
结论:
- 一个新的分类系统为水凝栓塞剂提供了有价值的见解.
- 这一框架可以指导材料科学家和干预放射学家在开发创新的TAE剂方面.
- 开发先进的多功能水凝是未来的一个关键方向.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2